Genetic Variation Screening for Autism Spectrum Disorder
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for identifying and managing genetic variations associated with Autism Spectrum Disorder (ASD) and other Pervasive Developmental Disorders (PDD), which hinders effective screening and treatment approaches.
Innovation Solution
A method involving genetic sample analysis using high-throughput sequencing techniques to detect specific genetic variations, such as point mutations, polymorphisms, and copy number variations, to diagnose and predict susceptibility to PDDs like ASD, and to select appropriate therapeutic agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If high-throughput sequencing techniques are used to detect genetic variations, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent segments the complex sequencing task into multiple components: library preparation, sequencing reaction, and data analysis. It further divides the sequencing process into cycles of denaturation, annealing, and extension steps, allowing each component to be optimized independently while maintaining overall system precision for detecting genetic variations associated with PDDs.
2Reliability
If comprehensive genetic screening is performed to identify all genetic variations, then reliability of diagnosis is improved, but loss of time increases
Solution Approach 1:
The patent performs preliminary actions by first conducting a comprehensive genetic screening to identify all potential genetic variations, including SNPs, CNVs, and structural variants. This initial broad assessment establishes a complete genetic profile that can then be used to guide more focused diagnostic evaluations, ensuring no potential risk factors are missed while streamlining subsequent diagnostic steps.
Solution Approach 2:
The patent implements feedback mechanisms where sequencing results are continuously analyzed and interpreted against known PDD-associated genetic variants. The system provides real-time feedback on detected variations, allowing for dynamic adjustment of screening parameters and prioritization of clinically significant findings, thereby improving diagnostic reliability without proportionally increasing screening time.
3Adaptability or versatility
If multiple genetic variations are detected to enable personalized treatment, then adaptability of treatment is improved, but loss of information increases
Solution Approach 1:
The patent introduces an intermediary layer of bioinformatics analysis and interpretation between raw sequencing data and clinical decision-making. This intermediary system integrates multiple detected genetic variations, correlates them with PDD phenotypes, and translates complex genomic data into actionable treatment recommendations. This mediator manages the information complexity by organizing vast genetic data into clinically relevant patterns while preserving all necessary information for personalized treatment planning.
Data Source
AI summary
This document provides methods and materials related to genetic variations of developmental disorders. For example, this document provides methods for using such genetic variations to assess susceptibility of developing Autism Spectrum Disorder.